Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 266

    USFDA finds deficiencies in Mylans generic Advair

    USFDA finds deficiencies in Mylan's generic Advair

    Ruby Khatun Khatun17 Jun 2018 9:41 AM IST
    Mylan NV said that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline’s blockbuster inhaled lung drug Advair for the...
    StatsMetrika introduces CDISC solutions in India

    StatsMetrika introduces CDISC solutions in India

    Medical Dialogues Bureau17 Jun 2018 9:41 AM IST
    New Delhi: Healthcare solutions provider StatsMetrika launched CDISC (Clinical Data Interchange Standards Consortium) Standards, for the first time in...
    Reddys Laboratories gets USFDA nod for generic version of Suboxone

    Reddy's Laboratories gets USFDA nod for generic version of Suboxone

    Medical Dialogues Bureau16 Jun 2018 1:34 PM IST
    New Delhi: Dr Reddy's Laboratories has received final approval from the US health regulator for generic version of Suboxone, prescribed for opioid...
    Setback for Sanofi : Study confirms higher risk of dengue in kids who got Sanofi vaccine

    Setback for Sanofi : Study confirms higher risk of dengue in kids who got Sanofi vaccine

    Medical Dialogues Bureau16 Jun 2018 10:13 AM IST
    CHICAGO (Reuters) - An analysis of data on Sanofi’s dengue vaccine, which has been given to more than 800,000 school children in the Philippines,...
    Lupin launches generic Tobramycin Inhalation Solution USP in the US

    Lupin launches generic Tobramycin Inhalation Solution USP in the US

    Medical Dialogues Bureau16 Jun 2018 10:00 AM IST
    Pharma Major Lupin has announced the launch of its Tobramycin Inhalation Solution USP, having received an approval from the United States Food and...
    Alembic Pharma gets USFDA nod for its Doxycycline Hyclate capsules

    Alembic Pharma gets USFDA nod for its Doxycycline Hyclate capsules

    Medical Dialogues Bureau16 Jun 2018 10:00 AM IST
    Drug firm Alembic Pharmaceuticals today said it has received approval from the US health regulator for its Doxycycline Hyclate capsules used for...
    Strides Shasun shares rise over 5% on USFDA approval for new drug

    Strides Shasun shares rise over 5% on USFDA approval for new drug

    Medical Dialogues Bureau16 Jun 2018 9:12 AM IST
    New Delhi: Shares of Strides Shasun rose by over 5 per cent after the company's subsidiary Strides Pharma Global received final approval from the US...
    Lupin launches generic antibiotic inhalation solution in US

    Lupin launches generic antibiotic inhalation solution in US

    Ruby Khatun Khatun15 Jun 2018 10:30 AM IST
    New Delhi: Drug firm Lupin said it has launched its antibiotic Tobramycin inhalation solution in the US market.The company has launched the product as...
    OmniVision introduces smallest HD medical image sensor for endoscopes and catheters

    OmniVision introduces smallest HD medical image sensor for endoscopes and catheters

    Ruby Khatun Khatun15 Jun 2018 10:15 AM IST
    SANTA CLARA: OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions announced from MD&M East in NYC the OH01A,...
    Apollo Munich Health Insurance launches Roshini to empower women

    Apollo Munich Health Insurance launches Roshini to empower women

    Medical Dialogues Bureau15 Jun 2018 10:00 AM IST
    New Delhi: Apollo Munich Health Insurance has launched its flagship initiative 'Roshini' to empower women from economically and socially weaker...
    China to conduct training programmes for Indian pharma cos on regulatory system

    China to conduct training programmes for Indian pharma cos on regulatory system

    Medical Dialogues Bureau15 Jun 2018 9:45 AM IST
    New Delhi: China has agreed to conduct specific training programmes for domestic pharmaceutical companies to understand their regulatory system, which...
    Johnson and Johnson accepts 2.1 billion dollar offer for its LifeScan unit

    Johnson and Johnson accepts 2.1 billion dollar offer for its LifeScan unit

    Ruby Khatun Khatun15 Jun 2018 9:30 AM IST
    Johnson and Johnson said on Tuesday it has accepted private equity firm Platinum Equity’s $2.1 billion buyout offer for the company’s LifeScan Inc...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok